Qitong Chen

595 total citations
29 papers, 259 citations indexed

About

Qitong Chen is a scholar working on Cancer Research, Molecular Biology and Oncology. According to data from OpenAlex, Qitong Chen has authored 29 papers receiving a total of 259 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Cancer Research, 10 papers in Molecular Biology and 9 papers in Oncology. Recurrent topics in Qitong Chen's work include Breast Cancer Treatment Studies (8 papers), Breast Lesions and Carcinomas (5 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Qitong Chen is often cited by papers focused on Breast Cancer Treatment Studies (8 papers), Breast Lesions and Carcinomas (5 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Qitong Chen collaborates with scholars based in China and Czechia. Qitong Chen's co-authors include Wenjun Yi, Qiongyan Zou, Dengjie Ouyang, Hongye He, Liyun Zeng, Tiangang Liu, Xixi Sun, Yu-Jie Yuan, Ying Wen and Yunxiang Liang and has published in prestigious journals such as Nature Communications, Journal of Agricultural and Food Chemistry and Scientific Reports.

In The Last Decade

Qitong Chen

26 papers receiving 257 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qitong Chen China 10 123 59 54 36 33 29 259
Lifang Liu China 10 150 1.2× 52 0.9× 60 1.1× 46 1.3× 30 0.9× 20 312
V. Sridevi India 11 78 0.6× 51 0.9× 49 0.9× 28 0.8× 13 0.4× 32 275
Meiqing Feng China 10 114 0.9× 43 0.7× 85 1.6× 19 0.5× 31 0.9× 21 328
Guanghui Lian China 9 110 0.9× 41 0.7× 67 1.2× 22 0.6× 12 0.4× 19 269
Guowen Yin China 11 96 0.8× 45 0.8× 61 1.1× 66 1.8× 27 0.8× 25 348
Lingxuan Zhu China 11 109 0.9× 47 0.8× 79 1.5× 29 0.8× 30 0.9× 27 317
Siqi Ren China 10 125 1.0× 52 0.9× 91 1.7× 37 1.0× 28 0.8× 34 318
Xiaohui Ye China 9 110 0.9× 35 0.6× 35 0.6× 28 0.8× 13 0.4× 24 324
Yun Su China 12 176 1.4× 78 1.3× 49 0.9× 26 0.7× 26 0.8× 27 345

Countries citing papers authored by Qitong Chen

Since Specialization
Citations

This map shows the geographic impact of Qitong Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qitong Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qitong Chen more than expected).

Fields of papers citing papers by Qitong Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qitong Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qitong Chen. The network helps show where Qitong Chen may publish in the future.

Co-authorship network of co-authors of Qitong Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Qitong Chen. A scholar is included among the top collaborators of Qitong Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qitong Chen. Qitong Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zeng, Chunyu, Xiaofei Wei, Qitong Chen, et al.. (2025). mRNA-engineered CRISPR-Cas epigenetic editors enable durable and efficient gene silencing in vivo. The Innovation. 7(3). 101151–101151.
2.
3.
Chen, Qitong & Qin Zhou. (2024). Identification of exosome-related gene signature as a promising diagnostic and therapeutic tool for breast cancer. Heliyon. 10(8). e29551–e29551. 4 indexed citations
4.
Peng, Jing, Qitong Chen, Danhua Zhang, et al.. (2024). Comparison of neoadjuvant chemotherapy response and prognosis between HR-low/HER2-negative BC and TNBC: an exploratory real-world multicentre cohort study. Frontiers in Endocrinology. 15. 1347762–1347762. 1 indexed citations
5.
Wang, Zhongzhi, et al.. (2023). Deep learning-based multifeature integration robustly predicts central lymph node metastasis in papillary thyroid cancer. BMC Cancer. 23(1). 128–128. 22 indexed citations
6.
Wen, Ying, Liyun Zeng, Qitong Chen, et al.. (2023). RNA-Seq-based transcriptomics analysis during the photodynamic therapy of primary cells in secondary hyperparathyroidism. Photochemical & Photobiological Sciences. 22(4). 905–917. 4 indexed citations
7.
Ouyang, Dengjie, Tao Hong, Yitong Li, et al.. (2023). METTL3 depletion contributes to tumour progression and drug resistance via N6 methyladenosine-dependent mechanism in HR+HER2—breast cancer. Breast Cancer Research. 25(1). 19–19. 16 indexed citations
8.
Zhu, Jinfeng, Qitong Chen, Liyun Zeng, et al.. (2023). Multi-omics analysis reveals the involvement of origin recognition complex subunit 6 in tumor immune regulation and malignant progression. Frontiers in Immunology. 14. 1236806–1236806.
9.
10.
Sun, Xixi, Yu-Jie Yuan, Qitong Chen, et al.. (2022). Metabolic pathway assembly using docking domains from type I cis-AT polyketide synthases. Nature Communications. 13(1). 5541–5541. 33 indexed citations
11.
Chen, Qitong, Qin Zhou, Hongye He, et al.. (2022). Chemotherapy significantly improves long-term survival of small lesion node negative metaplastic breast carcinoma in T1c population rather than T1a and T1b. Scientific Reports. 12(1). 871–871. 4 indexed citations
12.
13.
Wan, Jian, Liwei Duan, Qitong Chen, et al.. (2022). Potential clinical impact of metagenomic next-generation sequencing of plasma for cervical spine injury with sepsis in intensive care unit: A retrospective study. Frontiers in Cellular and Infection Microbiology. 12. 948602–948602. 2 indexed citations
14.
Luo, Na, Ying Wen, Qiongyan Zou, et al.. (2022). Construction and validation of a risk prediction model for clinical axillary lymph node metastasis in T1–2 breast cancer. Scientific Reports. 12(1). 687–687. 8 indexed citations
15.
Zeng, Liyun, Qiongyan Zou, Peng Huang, et al.. (2021). Inhibition of autophagy with Chloroquine enhanced apoptosis induced by 5-aminolevulinic acid-photodynamic therapy in secondary hyperparathyroidism primary cells and organoids. Biomedicine & Pharmacotherapy. 142. 111994–111994. 15 indexed citations
16.
Chen, Qitong, Liyun Zeng, Tao Hong, et al.. (2021). Prognosis Comparison Between Nipple-Sparing Mastectomy and Total Mastectomy in Breast Cancer: A Case-Control Study After Propensity Score Matching. Annals of Surgical Oncology. 29(4). 2221–2230. 13 indexed citations
17.
Liu, Huanming, Qitong Chen, Weiwei Dong, et al.. (2021). Detection of viable and total fungal community in zaopei of Chinese strong-flavor baijiu using PMA combined with qPCR and HTS based on ITS2 region. BMC Microbiology. 21(1). 274–274. 18 indexed citations
18.
Dong, Weiwei, Qitong Chen, Yuxin Cui, et al.. (2020). Heterologous expression of AHL lactonase AiiK by Lactobacillus casei MCJΔ1 with great quorum quenching ability against Aeromonas hydrophila AH-1 and AH-4. Microbial Cell Factories. 19(1). 191–191. 19 indexed citations
19.
Chen, Qitong, Liyun Zeng, Dengjie Ouyang, et al.. (2019). Surgery of the Primary Tumor Offers Survival Benefits of Breast Cancer with Synchronous Ipsilateral Supraclavicular Lymph Node Metastasis. World Journal of Surgery. 44(4). 1163–1172. 3 indexed citations
20.
Zhao, Piao, Qiongyan Zou, Liqin Yuan, et al.. (2018). Application of a Three-Dimensional Reconstruction System in Breast Cancer with Ipsilateral Supraclavicular Lymph Node Metastasis: A Case Series. Breast Care. 14(3). 176–179. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lifang Liu Breakdown of academic impact, for papers by V. Sridevi Breakdown of academic impact, for papers by Meiqing Feng Breakdown of academic impact, for papers by Guanghui Lian Breakdown of academic impact, for papers by Guowen Yin Breakdown of academic impact, for papers by Lingxuan Zhu Breakdown of academic impact, for papers by Siqi Ren Breakdown of academic impact, for papers by Xiaohui Ye Breakdown of academic impact, for papers by Yun Su
Rankless by CCL
2026